ScholarIQanswers from OpenAlex

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei

PaperCitations, authors & open-access status

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei have?

ScholarIQcitation count

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei has 51 citations in the OpenAlex counts ScholarIQ stores.

When was Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei published?

ScholarIQyear

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei has 2002 year in the ScholarIQ index.

What is the open-access status of Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei?

ScholarIQoa status

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei has closed oa status in the ScholarIQ index.

What is the DOI of Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei?

ScholarIQdoi

The DOI for Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei is on the source record.

What is the PMID of Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei?

ScholarIQpmid

The PMID for Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei is on the source record.

What is the OpenAlex record for Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei?

ScholarIQopenalex

The OpenAlex for Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial